Related Experiment Video
Updated: Oct 3, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations
N Leone1, R Pellicano, I Ariata Maiocco
1Department of Gastroenterology, Molinette Hospital, Turin, Italy. leone.nic@tiscolinet.it
Insights
Rheumatologic symptoms are common in patients with chronic hepatitis C virus (HCV) infection and cryoglobulinemia. These symptoms significantly impact quality of life, suggesting HCV should be considered in diagnosing unexplained rheumatologic conditions.
Area of Science:
- Rheumatology
- Hepatology
- Infectious Diseases
Background:
- Chronic hepatitis C virus (HCV) infection is linked to cryoglobulinemia.
- Mixed cryoglobulinemia can manifest with various rheumatologic symptoms.
Purpose of the Study:
- To investigate the prevalence of rheumatologic symptoms in patients with HCV-associated cryoglobulinemia.
- To assess the characteristics of cryoglobulins and associated rheumatologic manifestations.
Main Methods:
- 114 patients with chronic HCV and cryoglobulinemia were analyzed.
- Cryoglobulin type, concentration, rheumatoid factor (RF), and antinuclear antibody (ANA) were measured.
- Rheumatologic symptoms were assessed via anamnesis and clinical evaluation.
Main Results:
- 44.7% of patients reported rheumatologic symptoms, with a higher mean cryocrit value (2.6%) compared to asymptomatic patients (<0.5%).
- HCV genotype 1b was most prevalent (76%).
- RF was present in 31.5% and ANA in 3.5% of patients at low titers.
Conclusions:
- HCV infection is associated with a significant frequency of diverse rheumatologic manifestations.
- These symptoms negatively affect patients' quality of life.
- HCV should be considered in the differential diagnosis of unexplained rheumatologic symptoms.
Abstract:
The prevalence of rheumatologic symptoms in patients with mixed cryoglobulinaemia associated to chronic hepatitis C virus (HCV) infection was investigated. One hundred fourteen patients (96 female, mean age 63.5 years) with chronic HCV infection and cryoglobulinaemia were recruited. The presence, concentration, and type of cryoglobulins were tested by immunofixation. Rheumatoid factor (RF) and antinuclear antibody (ANA) were also measured. Rheumatological related symptoms were investigated by anamnesis and clinical evaluation. HCV genotype was determined by polymerase chain reaction (PCR) with genotype specific primer. Type II cryoglobulinaemia was identified in 39 cases and it was of type III in 58. HCV-RNA genotype was determined in 62 patients: 47 (76%) were infected by genotype1b, 8 (13%) by genotype 2a, while other genotypes were less common. RF and ANA were, respectively, present in 36 (31.5 %) and 4 (3.5 %) patients at low titre (RF < 50 UI/ml, ANA < 1:80). Of the 114 patients, 51 (44.7%) complained for rheumatological symptoms. The mean cryocrit value in these patients was 2,6 %, while in patients with HCV infection, liver disease, and cryoglobulinaemia without rheumatological symptoms the cryocrit value was lower than 0.5% in 50% of cases. It is concluded that patients with chronic HCV infection reported a wide variety of rheumatological manifestations, impairing their quality of life, with discrete frequency. These results suggest that HCV infection should be considered in the differential diagnosis of rheumatological symptoms of unknown origin.
Related Concept Videos
Hepatitis
Cirrhosis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cytomegalovirus Disease
Viral Hepatitis I: Introduction
Rheumatic Heart Disease I: Introduction
